micro-computerised tomography milabs uspect-ii Search Results


uspect ii micro spect scanner  (MILabs)
97
MILabs uspect ii micro spect scanner
FIGURE 1. <t>(A)</t> <t>Micro-SPECT</t> images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab-IRDye800CW. In addition to tumor uptake, minimal uptake in heart and thyroid was observed. (B) Optical images of same mouse at 1 and 3 d after injection (same image settings were used for days 1 and 3). Some reflectance-induced image artifacts on backs of mice were observed. (C) Micro-SPECT images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab. (D) Biodistribution of 125I-girentuximab-IRDye800CW and 125I-girentuximab in mice with subcutaneous SK-RC-52 tumor at 3 d after injection. Values are expressed as mean ± SD. T/B ratio 5 tumor-to-blood ratio.
Uspect Ii Micro Spect Scanner, supplied by MILabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro-computerised+tomography+milabs+uspect-ii/pm24752673-89-6-10?v=MILabs
Average 97 stars, based on 1 article reviews
uspect ii micro spect scanner - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

Image Search Results


FIGURE 1. (A) Micro-SPECT images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab-IRDye800CW. In addition to tumor uptake, minimal uptake in heart and thyroid was observed. (B) Optical images of same mouse at 1 and 3 d after injection (same image settings were used for days 1 and 3). Some reflectance-induced image artifacts on backs of mice were observed. (C) Micro-SPECT images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab. (D) Biodistribution of 125I-girentuximab-IRDye800CW and 125I-girentuximab in mice with subcutaneous SK-RC-52 tumor at 3 d after injection. Values are expressed as mean ± SD. T/B ratio 5 tumor-to-blood ratio.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Article Title: Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

doi: 10.2967/jnumed.114.137356

Figure Lengend Snippet: FIGURE 1. (A) Micro-SPECT images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab-IRDye800CW. In addition to tumor uptake, minimal uptake in heart and thyroid was observed. (B) Optical images of same mouse at 1 and 3 d after injection (same image settings were used for days 1 and 3). Some reflectance-induced image artifacts on backs of mice were observed. (C) Micro-SPECT images of mouse bearing SK-RC-52 tumor on right flank (arrow) at 1 and 3 d after injection of 125I-girentuximab. (D) Biodistribution of 125I-girentuximab-IRDye800CW and 125I-girentuximab in mice with subcutaneous SK-RC-52 tumor at 3 d after injection. Values are expressed as mean ± SD. T/B ratio 5 tumor-to-blood ratio.

Article Snippet: Micro-SPECT images were acquired with a USPECT II micro-SPECT scanner (MILabs) by use of the GP-RM 1.0-mm collimator tube with 75 pinholes (18).

Techniques: Micro-SPECT, Injection